Kare Family Trust Acquires 6% Stake in Indoco Remedies, Enhancing Promoter Holding
Kare Family Private Trust (KFPT), with Aditi Milind Panandikar and Madhura Suresh Kare as trustees, has acquired 55,34,874 equity shares of Indoco Remedies Limited, representing 6.00% of the total sha...
Limitations of AI summaries
AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.
Platforms like Prysm provide stock-level and portfolio-level analysis.
Why is Indoco Remedies Limited in the news today?
Indoco Remedies Limited (INDOCO) is in the news due to the acquisition of shares by a promoter trust and the consolidation of holdings are generally viewed positively as they indicate continued promoter confidence and strategic restructuring for succession planning.
AI-Powered Summary
Market Context
Top Queries
More News
Explore Prysm Tools
Related Stories
Kare Family Trust Acquires 6% Stake in Indoco Remedies, Enhancing Promoter Holding
December 30, 2025, 12:02 PM
Top Queries to Ask About Indoco Remedies Limited
More Details on This News
Kare Family Private Trust (KFPT), with Aditi Milind Panandikar and Madhura Suresh Kare as trustees, has acquired 55,34,874 equity shares of Indoco Remedies Limited, representing 6.00% of the total share capital. This acquisition was an off-market, inter-se transfer among immediate relatives, with Aruna Suresh Kare being the seller. The transaction is part of a family arrangement for smooth succession planning and to streamline family assets and businesses.
Furthermore, KFPT indirectly acquired shares in Indoco Remedies by acquiring stakes in promoter companies Shanteri Investment Private Limited (SIPL) and SPA Holdings Private Limited (SHPL). KFPT acquired 40.00% (40,000 shares) of SIPL and 20.16% (1,24,933 shares) of SHPL from Aruna Suresh Kare. These acquisitions result in KFPT indirectly holding a significant stake in Indoco Remedies through these promoter entities.
Following these transactions, the direct shareholding of KFPT in Indoco Remedies increased to 14.20% (1,30,97,055 shares), while its indirect shareholding through SIPL remained at 17.19% (1,58,58,805 shares) and through SHPL at 19.88% (1,83,35,000 shares). Consequently, Aruna Suresh Kare's direct shareholding reduced from 6.00% to 0.00%. This disclosure was made under Regulation 10(6) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, with the disclosure under Regulation 10(5) being filed on 18th December, 2025, at least four working days prior to the acquisition on 26th December, 2025.
See What Deep Dive Gives You — in Seconds
“what happens when you click
Deep Dive “
“what happens when you click Deep Dive “
Instant AI Summary - “Get clean, noise-free earnings breakdowns.”
PDF Insights - “Download detailed, AI-generated reports.”
Metrics Explained -“Key ratios & trends explained in simple language.”
Want to know if this news pushes your stock up or down?
Just tap